Dosing and delivery of a recombinant surfactant in lung-injured adult sheep

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 3, 1999, Pages 741-747

  Lewis, Jim ^a,b,c,d   McCaig, Lynda ^a,b,c   Häfner, Dietrich ^a,b,c   Spragg, Roger ^a,b,c   Veldhuizen, Ruud ^a,b,c   Kerr, Carolyn ^a,b,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALTANA PHARMA AG   (Germany)

^d ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN C;

ANIMAL MODEL; ARTICLE; BRONCHOSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; GAS EXCHANGE; INSPIRATORY CAPACITY; LUNG INJURY; NONHUMAN; OXYGEN CONSUMPTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SHEEP; TIDAL VOLUME; TREATMENT OUTCOME;

EID: 0033053846     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.3.9806069     Document Type: Article

References (26)

1. 1. Dunn, M. S., A. T. Shennan, D. Zayack, and F. Possmayer. 1991. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Pediatrics 87:377-386.
2. 2. Dunn, M. S., A. T. Shennan, E. M. Hoskins, K. Lennox, and G. Enhorning. 1988. Two-year follow-up of infants enrolled in a randomized trial of surfactant replacement therapy for prevention of neonatal respiratory distress syndrome. Pediatrics 82:543-547.
3. 3. Anzueto, A., R. P. Baughman, K. K. Guntupalli, J. G. Weg, H. P. Wiedemann, A. Artigas Raventos, F. Lemaire, W. Long, D. S. Zaccardelli, and E. N. Pattishall. 1996. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N. Engl. J. Med. 334: 1417-1421.
4. 4. Walmrath, D., A. Gunther, H. Ardeschir, R. Schermuly, T. Schneider, F. Grimminger, and W. Seeger. 1996. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am. J. Respir. Crit. Care Med. 154:57-62.
5. 5. Gregory, T. J., K. P. Steinberg, R. Spragg, J. E. Gadek, T. M. Hyers, W. J. Longmore, M. A. Moxley, G. Z. Cai, R. D. Hite, R. M. Smith, L. D. Hudson, C. Crim, P. Newton, B. R. Mitchell, and A. J. Gold. 1997. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155:1309-1315.
6. 6. Lewis, J. F., and R. A. W. Veldhuizen. 1995. Factors influencing efficacy of exogenous surfactant in acute lung injury. Biol. Neonate. 67(Suppl. 1):48-60.
7. 7. Hafner, D., P. G. Germann, and D. Hauschke. 1994. Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF. Pulm. Pharmacol. 7:319-332.
8. 8. Hafner, D., P. G. Germann, and D. Hauschke. 1998. Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury. Am. J. Respir. Crit. Care Med. 158:270-278.
9. 9. Davis, A. J., A. H. Jobe, D. Hafner, and M. Ikegami. 1998. Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am. J. Respir. Crit. Care Med. 157:553-559.
10. 10. Hawgood, S., A. Ogawa, K. Yukitake, M. Schlueter, C. Brown, T. White, D. Buckley, D. Lesikar, and B. Benson. 1996. Lung function in premature rabbits treated with recombinant human surfactant protein-C. Am. J. Respir. Crit. Care. Med. 154(Pt. 1):484-490.
11. 11. Lewis, J. F., B. Tabor, M. Ikegami, A. H. Jobe, M. Joseph, and D. Absolom. 1993. Lung function and surfactant distribution in saline lavaged sheep given instilled vs. nebulized surfactant. J. Appl. Physiol. 74: 1256-1264.
12. 12. Lewis, J. F., J. Goffin, P. Yue, L. A. McCaig, D. Bjarneson, and R. A. W. Veldhuizen. 1996. Evaluation of delivery methods for two exogenous surfactant preparations in an animal model of acute lung injury. J. Appl. Physiol. 80:1156-1164.
13. 13. Lewis, J. F., R. Veldhuizen, F. Possmayer, W. Sibbald, J. Whitsett, R. Qanbar, and L. McCaig. 1994. Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep. Am. J. Respir. Crit. Care Med. 150:123-130.
14. 14. Duck-Chong, C. G. 1979. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids 14:492-497.
15. 15. Gilliard, N., P. M. Richman, T. A. Merritt, and R. G. Spragg. 1990. Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury. Am. Rev. Respir. Dis. 141:743-747.
16. 16. VanDerBleek, J., F. B. Plotz, F. M. VanOverbeek, A. Heikamp, H. Beekhuis, C. R. H. Wildevuur, A. Okken, and S. B. Oetomo. 1993. Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume. Pediatr. Res. 34:154-158.
17. 17. Holm, B. A., A. R. Venkitaraman, G. Enhorning, and R. H. Notter. 1990. Biophysical inhibition of synthetic lung surfactants. Chem. Phys. Lipids 52:243-250.
18. 18. Holm, B. A., G. Enhorning, and R. H. Notter. 1988. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem. Phys. Lipids 49:49-55.
19. 19. Seeger, W., G. Stohr, H. R. Wolf, and H. Neuhof. 1985. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J. Appl. Physiol. 58:326-338.
20. 20. Spragg, R. G., N. Gilliard, P. Richman, R. M. Smith, R. D. Hite, D. Pappert, B. Robertson, T. Curstedt, and D. Strayer. 1994. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 105:195-202.
21. 21. Findlay, R. D., H. W. Taeusch, and F. J. Walther. 1996. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 97: 48-52:
22. 22. Beers, M. F., and A. B. Fisher. 1992. Surfactant protein C: a review of its unique properties and metabolism. Am. J. Physiol. 263:L151-L160.
23. 23. Ito, Y., J. Goffin, R. Veldhuizen, M. Joseph, D. Bjarneson, L. McCaig, L.-J. Yao, J. Marcou, and J. Lewis. 1996. Timing of exogenous surfactant administration in a rabbit model of acute lung injury. J. Appl. Physiol. 80:1357-1364.
24. 24. Veldhuizen, R. A. W., J. Marcou, L.-J. Yao, L. McCaig, Y. Ito, and J. F. Lewis. 1996. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am. J. Physiol. 270:L152-L158.
25. 25. Ito, Y., R. A. W. Veldhuizen, L.-J. Yao, L. A. McCaig, A. J. Bartlett, and J. F. Lewis. 1997. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. Am. J. Respir. Crit. Care Med. 155: 493-499.
26. 26. Veldhuizen, R. A., L. A. McCaig, T. Akino, and J. F. Lewis. 1995. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 152:1867-1871.